336 related articles for article (PubMed ID: 29466775)
1. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease.
Hiremathad A; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
Eur J Med Chem; 2018 Mar; 148():255-267. PubMed ID: 29466775
[TBL] [Abstract][Full Text] [Related]
2. New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease.
Rajeshwari R; Chand K; Candeias E; Cardoso SM; Chaves S; Santos MA
Molecules; 2019 Feb; 24(3):. PubMed ID: 30736397
[TBL] [Abstract][Full Text] [Related]
3. Multi-Targeting Tacrine Conjugates with Cholinesterase and Amyloid-Beta Inhibitory Activities: New Anti-Alzheimer's Agents.
Hiremathad A; Chaves S; Keri RS
Chem Biodivers; 2021 Feb; 18(2):e2000083. PubMed ID: 33448662
[TBL] [Abstract][Full Text] [Related]
4. Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug.
Chand K; Rajeshwari ; Candeias E; Cardoso SM; Chaves S; Santos MA
Metallomics; 2018 Oct; 10(10):1460-1475. PubMed ID: 30183790
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
8. Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease.
Fancellu G; Chand K; Tomás D; Orlandini E; Piemontese L; Silva DF; Cardoso SM; Chaves S; Santos MA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):211-226. PubMed ID: 31760822
[TBL] [Abstract][Full Text] [Related]
9. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.
Mao F; Huang L; Luo Z; Liu A; Lu C; Xie Z; Li X
Bioorg Med Chem; 2012 Oct; 20(19):5884-92. PubMed ID: 22944335
[TBL] [Abstract][Full Text] [Related]
10. New Tacrine Hybrids with Natural-Based Cysteine Derivatives as Multitargeted Drugs for Potential Treatment of Alzheimer's Disease.
Keri RS; Quintanova C; Chaves S; Silva DF; Cardoso SM; Santos MA
Chem Biol Drug Des; 2016 Jan; 87(1):101-11. PubMed ID: 26256122
[TBL] [Abstract][Full Text] [Related]
11. Tacrine-(hydroxybenzoyl-pyridone) hybrids as potential multifunctional anti-Alzheimer's agents: AChE inhibition, antioxidant activity and metal chelating capacity.
Chand K; Alsoghier HM; Chaves S; Santos MA
J Inorg Biochem; 2016 Oct; 163():266-277. PubMed ID: 27235273
[TBL] [Abstract][Full Text] [Related]
12. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.
Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K
Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055
[TBL] [Abstract][Full Text] [Related]
13. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
14. Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors.
Cheng ZQ; Song JL; Zhu K; Zhang J; Jiang CS; Zhang H
Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30134630
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and activity towards Alzheimer's disease in vitro: Tacrine, phenolic acid and ligustrazine hybrids.
Li G; Hong G; Li X; Zhang Y; Xu Z; Mao L; Feng X; Liu T
Eur J Med Chem; 2018 Mar; 148():238-254. PubMed ID: 29466774
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease.
Zhang C; Du QY; Chen LD; Wu WH; Liao SY; Yu LH; Liang XT
Eur J Med Chem; 2016 Jun; 116():200-209. PubMed ID: 27061983
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Li SY; Jiang N; Xie SS; Wang KD; Wang XB; Kong LY
Org Biomol Chem; 2014 Feb; 12(5):801-14. PubMed ID: 24310227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]